Drugs For Rare Diseases Have Become Uncommonly Rich Monopolies

Drugs For Rare Diseases Have Become Uncommonly Rich Monopolies

Drugmakers have brought almost 450 orphan drugs to market and collected rich incentives by doing so. But nearly a third of the medicines aren’t new or were repurposed many times for financial gain. By Sarah Jane Tribble, Sydney Lupkin.

View Full Post

More great content like this @ Health & Body Front Page or you can Request Invite

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s